Evidence map›Paper›PMID 31089875›Full record

ArticleInternational journal of colorectal disease2019

The incidence, associated factors, and predictive nomogram for early death in stage IV colorectal cancer.

Xin Wang, Min Mao, Guijun Xu, Feng Lin, Peng Sun, Vladimir P Baklaushev, Vladimir P Chekhonin, Karl Peltzer, Jin Zhang, Chao Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of colorectal disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 52 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Value analysis ofTranslational cancer research · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 3 countries.

Xin WangDepartment of Epidemiology and Biostatistics, First Affiliated Hospital, Army Medical University, Chongqing, China.
Min MaoDepartment of Pathology and Southwest Cancer Center, First Affiliated Hospital, Army Medical University, Chongqing, China.
Guijun XuDepartment of Bone and Soft Tissue Tumors, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Huanhu Xi Road, Tianjin, 300060, China.
Feng LinDepartment of Bone and Soft Tissue Tumors, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Huanhu Xi Road, Tianjin, 300060, China.
Peng SunDepartment of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Vladimir P BaklaushevFederal Research and Clinical Center of Specialized Medical Care and Medical Technologies, Federal Biomedical Agency of the Russian Federation, Moscow, Russian Federation.
Vladimir P ChekhoninDepartment of Basic and Applied Neurobiology, Federal Medical Research Center for Psychiatry and Narcology, Moscow, Russian Federation.
Karl PeltzerDepartment of Research and Innovation, University of Limpopo, Turfloop, Mankweng, South Africa.
Jin ZhangDepartment of Bone and Soft Tissue Tumors, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Huanhu Xi Road, Tianjin, 300060, China. dczhangj@163.com.
Chao ZhangDepartment of Bone and Soft Tissue Tumors, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Huanhu Xi Road, Tianjin, 300060, China. drzhangchao@tmu.edu.cn.
Tianjin Medical University Cancer Institute and Hospital · CNArmy Medical University · CNFederal Medical-Biological Agency · RUFederal Medical Research Centre for Psychiatry and Narcology · RUSecond Affiliated Hospital of Harbin Medical University · CNSouthwest Hospital · CNUniversity of Limpopo · ZA

Funding

DYSREGULATION OF C-MYC BY EBV IN AIDS LYMPHOMASK04CA001711 · NCI · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI KENNEY, SHANNON CELESTE · 1992 to 1996
–
atural Science Foundation of Tianjin Medical University 2016KYZQ10Doctor Start-up Grant of Tianjin Medical University Cancer Institute and Hospital B1711Natural Science Foundation of China 81702161Natural Science Foundation of China 81801781Natural Science Foundation of China 81802508Natural Science Foundation of the Tianjin Science and Technology Committee of China 17JCQNJC11000Top talent training program of the first affiliated hospital of PLA Army Medical University SWH2018BJKJ-12
6 · The paper itself

Abstract

purposeThe purpose of the present study was to investigate the incidence and associated factors for early death in stage IV colorectal cancer (CRC) and to construct the predictive nomogram.

methodsPatients with stage IV CRC, who had been diagnosed between 2010 and 2014 in the Surveillance, Epidemiology, and End Results datasets, were eligible for this retrospective cohort study. The univariable and multivariable logistic regression models were conducted to determine the associated factors for early death (survival time ≤ 3 months). The predictive nomogram was constructed and the internal validation was performed.

resultsTen thousand two hundred sixty-three out of 36,461 (28.1%) eligible patients resulted in all causes of early death (25.8% for cancer-specific early death and 2.3% for non-cancer early death). Advanced age, marital status, right colon, poor differentiation, higher N stage, and bone metastasis were positively associated with all causes of early death, cancer-specific early death, and non-cancer early death, while higher T stage, positive carcinoembryonic antigen, and distant metastases (bone, lung, liver, and brain) were only positively associated with all causes of early death and cancer-specific early death. The calibration curve for all causes of early death, cancer-specific early death, and non-cancer early death showed the prediction curve closely approximated at the 45° line and the areas under the curve were 75.7% (95% CI, 74.9-76.4%), 75.9% (95% CI, 75.1-76.6%), and 76.9% (95% CI, 76.3-77.6%), respectively.

conclusionsThe nomogram was calibrated to predict all causes of early death development, cancer-specific early death development, and non-cancer early death development. These findings can be utilized in early screening and to tailor targeted treatment regimens for stage IV CRC patients.

Indexed as

NomogramsAgedAged, 80 and overCalibrationColorectal NeoplasmsFemaleHumansIncidenceLogistic ModelsMaleMiddle AgedMultivariate AnalysisNeoplasm StagingRisk FactorsROC CurveColorectal cancerEarly deathNomogramSEERStage IV

Identifiers

PMID31089875
OpenAlexW2945344996

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.